Diagnoses using molecular biomarkers

Israel’s ImmunArray is developing blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases, including brain injury. It has just received a major investment from America’s Quanterix Corporation.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *